References
Ram R, Bonstein L, Gafter-Gvili A, Ben-Bassat I, Shpilberg O, Raanani P (2009) Rituximab- associated acute thrombocytopenia: an under-diagnosed phenomenon. Am J Hematol 84:247–50
Yi JH, Kim SJ, Ahn HK, Lee SJ, Chang MH, Kim WS (2009) Rituximab-induced acute thrombocytopenia: a case report and review of the literature. Med Oncol 26:45–8
Larrar S, Guitton C, Willems M, Bader-Meunier B (2006) Severe hematological side effects following Rituximab therapy in children. Haematologica 91(8 Suppl):ECR36
Pilon VA, Davey FR, Gordon GB, Jones DB (1982) Splenic alterations in hairy-cell leukemia: II. An electron microscopic study. Cancer 49:1617–23
Wilkins B, Wright DH (2000) Illustrated pathology of the spleen, chapter 6. Cambridge University Press, Cambridge, p 83
Mollejo M, Algara P, Mateo MS, Sánchez-Beato M, Lloret E, Medina MT et al (2002) Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma? Histopathology 40:22–30
Chuang SS, Li CF, Lu D, Tsai TC, Tsao CJ (2006) Splenic marginal zone lymphoma with predominant red pulp involvement lacking p53 overexpression. J Clin Pathol 59:1226–8
Myhre Jensen O, Kristensen J (1986) Red pulp of the spleen in autoimmune haemolytic anaemia and hereditary spherocytosis: morphometric light and electron microscopy studies. Scand J Haematol 36:263–6
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adiyodi, J., Thachil, J., Hawkins, S. et al. Thrombocytopenia with rituximab treatment—splenomegaly as the risk factor. Ann Hematol 89, 95–96 (2010). https://doi.org/10.1007/s00277-009-0768-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-009-0768-9